An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and sy...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning ulcerative colitis
Updated Feb 4, 2026
Eli Lilly reported $19.3 billion in revenue for Q4 and is expanding its GLP-1 franchise into immunology and inflammation. Ongoing trials target asthma, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
Organizations with orphan designations or approved therapies for this disease
ANI Pharmaceuticals, Inc.
Other
AbbVie Inc.
Other
Celgene Corporation
Other
Coherus BioSciences Inc
Other
Janssen Biotech, Inc.
Other
Pfizer Laboratories Div Pfizer Inc
Other
Pharmacia & Upjohn Company LLC
Other
Seton Pharmaceuticals, LLC
Other
4D Pharma Research Ltd
Other
Aliment Wellness LLC
Other
Eli Lilly & Company
Other
InDex Pharmaceuticals AB
Other
Takeda Development Center Americas, Inc.
Other